We are live on ! Find out more
RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.7B
1-Year Est. Return 93.03%
This Fund
S&P 500
This Quarter Est. Return
+8.03%
1 Year Est. Return
+93.03%
3 Year Est. Return
+228.43%
5 Year Est. Return
+368.14%
10 Year Est. Return
+4,607.77%
AUM
$646M
AUM Growth
+$88.7M
Cap. Flow
+$74.4M
Cap. Flow %
11.51%
Top 10 Hldgs %
39.44%
Holding
93
New
15
Increased
55
Reduced
6
Closed
10

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$15.4M
2
ABBV icon
AbbVie
ABBV
+$13.9M
3
MDT icon
Medtronic
MDT
+$7.15M
4
DHR icon
Danaher
DHR
+$6.5M
5
AGN
Allergan plc
AGN
+$4.92M

Top Sells

Rank Stock Value
1
ITMN
INTERMUNE INC
ITMN
+$23.8M
2
STJ
St Jude Medical
STJ
+$6.92M
3
WBA
Walgreens Boots Alliance
WBA
+$5.93M
4
FRX
FOREST LABORATORIES INC
FRX
+$5.35M
5
CRL icon
Charles River Laboratories
CRL
+$3.81M

Sector Composition

Rank Sector Weight
1 Healthcare 79.22%
2 Industrials 2.23%
3 Financials 1.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
Gilead Sciences
GILD
$165B
$38.6M 5.98%
363,000
+23,000
+7% +$2.25M
MDT icon
2
Medtronic
MDT
$112B
$32.7M 5.06%
527,500
+112,500
+27% +$7.15M
ABBV icon
3
AbbVie
ABBV
$465B
$30.3M 4.69%
525,000
+250,000
+91% +$13.9M
MRK icon
4
Merck
MRK
$322B
$28.2M 4.36%
497,800
– –
MCK icon
5
McKesson
MCK
$104B
$25M 3.87%
128,500
+9,500
+8% +$1.83M
HCA icon
6
HCA Healthcare
HCA
$90.6B
$22.6M 3.49%
320,250
+232,750
+266% +$15.4M
AGN
7
DELISTED
Allergan plc
AGN
$21.2M 3.28%
87,750
+22,000
+33% +$4.92M
AMGN icon
8
Amgen
AMGN
$209B
$20.4M 3.15%
145,000
+30,000
+26% +$3.92M
BIIB icon
9
Biogen
BIIB
$30.9B
$20.3M 3.14%
61,350
+1,350
+2% +$445K
CELG
10
DELISTED
Celgene Corp
CELG
$15.7M 2.43%
166,000
+6,000
+4% +$541K
ALXN
11
DELISTED
Alexion Pharmaceuticals
ALXN
$14.9M 2.3%
89,750
+4,000
+5% +$657K
THOR
12
DELISTED
THORATEC CORPORATION
THOR
$13.9M 2.15%
521,000
+28,800
+6% +$818K
TMO icon
13
Thermo Fisher Scientific
TMO
$214B
$13.2M 2.04%
108,500
+500
+0.5% +$60.8K
AVNR
14
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$13.1M 2.03%
1,100,000
+400,000
+57% +$2.73M
COO icon
15
Cooper Companies
COO
$14.2B
$10.7M 1.66%
275,000
+23,000
+9% +$905K
AVDL
16
DELISTED
Avadel Pharmaceuticals
AVDL
$10.5M 1.63%
735,000
-40,000
-5% -$575K
HUM icon
17
Humana
HUM
$43.9B
$10.4M 1.6%
79,500
+7,000
+10% +$890K
CVS icon
18
CVS Health
CVS
$135B
$10.3M 1.6%
130,000
+8,750
+7% +$690K
PCYC
19
DELISTED
PHARMACYCLICS INC
PCYC
$10M 1.55%
85,250
+31,000
+57% +$3.53M
EVHC
20
DELISTED
Envision Healthcare Holdings Inc
EVHC
$9.9M 1.53%
95,357
+40,247
+73% +$4.27M
PCRX icon
21
Pacira BioSciences
PCRX
$1.04B
$9.89M 1.53%
102,000
+24,250
+31% +$2.36M
ACHC icon
22
Acadia Healthcare
ACHC
$2.52B
$9.85M 1.52%
203,000
+83,000
+69% +$4.06M
ATHN
23
DELISTED
Athenahealth, Inc.
ATHN
$8.92M 1.38%
67,750
+5,500
+9% +$724K
SRGA
24
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$8.89M 1.38%
61,987
+3,654
+6% +$530K
HRC
25
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$8.82M 1.37%
213,000
+18,000
+9% +$755K
1
2 3 4

Similar funds

AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
SGI
Summit Global Investments Bountiful, Utah $1.69B AUM 12.13% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
ISS
Intesa Sanpaolo SpA. Turin, Italy $1.69B AUM
PP
PDT Partners New York $1.69B AUM 74.01% 1-Year Est. Return
FDP
Financiere des Professionnels Montreal, Quebec, Canada $1.71B AUM 21.77% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Rock Springs Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, Rock Springs Capital Management held 93 positions worth $646M, up 16% from $558M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Rock Springs Capital Management deployed $74.4M of net new capital in Q3 2014, opening 15 new positions and adding to 55 existing holdings. Its largest new stake was Danaher: 126,466 shares worth $6.46M.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 76% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Cigna, an estimated $1.87M trimmed.

  • Rock Springs Capital Management's largest Q3 2014 buy was Danaher: 126,466 shares worth $6.46M.
  • Rock Springs Capital Management added most to HCA Healthcare in Q3 2014, an estimated $15.4M increase.
  • Rock Springs Capital Management's biggest Q3 2014 reduction was Cigna, cutting an estimated $1.87M.
  • Rock Springs Capital Management fully exited INTERMUNE INC in Q3 2014, selling an estimated $23.8M.
  • Rock Springs Capital Management's ten largest holdings make up 39% of its $646M portfolio in Q3 2014.
  • Rock Springs Capital Management opened 15 new positions and closed 10 in Q3 2014.
  • Rock Springs Capital Management's portfolio value rose 16% quarter-over-quarter to $646M.

Based on Rock Springs Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.